THEODORE E. WOODWARD, M.D.; JOSEPH E. SMADEL, M.D.; HERBERT L. LEY JR., M.D.; RICHARD GREEN, M.D.; D. S. MANKIKAR, M.D.
This content is PDF only. Please click on the PDF icon to access.
A new antibiotic Chloromycetin has been clinically tested in the treatment of typhoid fever and has been found to exhibit significant chemotherapeutic effects. A description of the results in 10 cases is submitted as a preliminary report.
Chloromycetin is a crystalline substance obtained through processes of concentration and purification of cultures in liquid media of a Streptomyces sp. originally isolated by Burkholder,2 and shown by him to possess anti-bacterial activity. Ehrlich and associates1 in the Research Laboratories of Parke, Davis and Company carried out studies of the antibiotic activity of this Streptomyces which led to preparation of the crystalline antibiotic
WOODWARD TE, SMADEL JE, LEY HL, et al. PRELIMINARY REPORT ON THE BENEFICIAL EFFECT OF CHLOROMYCETIN IN THE TREATMENT OF TYPHOID FEVER1. Ann Intern Med. 1948;29:131–134. doi: 10.7326/0003-4819-29-1-131
Download citation file:
Published: Ann Intern Med. 1948;29(1):131-134.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use